Scientists dig into genetic roots of rare bleeding disorders
NCT ID NCT00230165
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at how blood cells interact and what goes wrong in inherited bleeding disorders like Glanzmann thrombasthenia. Researchers will analyze blood samples from up to 60 healthy volunteers and patients to find genetic defects. The goal is to better understand these conditions, not to test a new treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this research could improve understanding of inherited bleeding disorders, potentially guiding future treatments.
- What could go wrong
- This is an observational study, not a treatment trial. It is small (60 participants) and focuses on understanding disease mechanisms, not curing or treating symptoms.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLANZMANN THROMBASTHENIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Rockefeller University Hospital
RECRUITINGNew York, New York, 10021, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Tiny camera may spot hidden bleeding in rare blood disorder
- New drug may offer longer-lasting bleed control for rare platelet disorder
- Rare bleeding disorder study seeks to unlock antibody mystery
- Trial for bleeding disorder drug in toddlers pulled before it started
- Tongue camera could spot bleeding danger in rare blood disorders
- New hope for kids with rare bleeding disease: study tests rVWF therapy